D iabetes is a complex chronic disease affecting multiple organ systems, often accompanied by other comorbid conditions and associated disease management burden for patients. Coronary heart disease (CHD) is a frequent complication of diabetes and its presence can create added complexity for an already burdensome regimen. Patients with type 2 diabetes also experience added burden from other, noncardiovascular comorbidities (eg, osteoarthritis, chronic obstructive pulmonary disease). 1, 2 Complex medication regimens that accompany a greater number of, and more severe comorbidities may overwhelm these patients, reducing adherence and resulting in poorer cardiovascular risk factor control. 3 Previous studies of medication adherence among patients with cardiac disease or its risk factors have documented the relationship between comorbidity burden and poor adherence to cardiovascular medications. [4] [5] [6] [7] Because cardiovascular risk factor control is a major contributor to mortality for diabetes patients, these findings are especially troubling. A recent study among patients with diabetes who also had other nondiabetes-related comorbidities, showed that these "complex" patients gave lower priority to diabetes self-management. 2 Not yet known is whether and to what extent the presence of cardiovascular disease may further contribute to the management burden of diabetes patients in ways that worsen control of cardiometabolic risk factors.
Using data from the on-going Reducing Racial Disparities in Diabetes Coached Care (R2D2C2) Study, 8, 9 this paper focused on the relationship between patient complexity, regimen intensity, problems with adherence to medications and control of cardiometabolic risk factors among type 2 diabetes patients with and without CHD. This is the first study to examine the specific contribution of burden from CHD versus that from complex noncardiovascular multimorbidity on simultaneous consideration of 3 markers of cardiometabolic risk.
METHODS

Study Sample and Data Collection
The data for this paper derive from the Reducing Racial Disparities in Diabetes Coached Care (R2D2C2) Study, 8, 9 which included patients with diabetes at 6 primary care clinics affiliated with an academic health system. Laboratory, administrative, and medical records data were abstracted for study measures.
Study Measures Dependent Variables
We created composite measure of risk factor control, the cardiometabolic risk management profile (CRMP), to assess the most common clinical targets for prevention of cardiovascular events for patients with diabetes: systolic blood pressure, low-density lipoprotein cholesterol, and hemoglobin A1c. These important risk factors are typically evaluated individually and not in combination, although recent research has considered these and other risk factors as composite predictors of cardiac morbidity and mortality. 10, 11 The CRMP was computed using equal weighting for the proportional distance above or below clinical targets for hemoglobin A1c level (r7%), systolic blood pressure (r130 mm Hg), and low-density lipoprotein cholesterol (r100 mg/dL), expressed as a percentage of each target value and averaged across all 3 indicators for each participant. If all 3 risk factors were exactly at target values, the cardiometabolic risk management profile (CRMP) score would be zero. Lower CRMP scores reflected better control of risk factors.
Independent Variables
To measure patient complexity, we used the "Potential for Benefit Scale" (PBS) previously tested 8 multidimensional composite of 5 preexisting measures of patients' health status and attitudes toward health care: comorbidity, physical function, mental health, diabetes burden, and a passive approach to health care. The PBS was scored as a weighted mean of the 5 measures, with weights determined by factor loadings on a single factor in principal components analysis. 8 Comorbidity was measured using a 38-item version of the total illness burden index (TIBI), [12] [13] [14] a summary measure of the presence and severity of the patient's diseases and symptoms comorbid to diabetes and heart disease. TIBI scores ranged from 0 to 10. To measure physical function, we used the 10-item Physical Function Scale of the Short-Form 36, for which scores reversed and converted to range from 0 to 10 with higher scores indicating poorer functioning. 15 To represent depressive symptomatology, we used a modified version of the Center for Epidemiologic Studies Depression Scale, 16 rescaled to the range of 0-10. To evaluate the disease-specific burden of diabetes, we used the 8-item Diabetes Burden Scale from the type 2 diabetes patient outcomes research team, converted to range from 0 to 10. 17, 18 To measure passivity, we used the Provider-Dependent Health Care Orientation Scale; scores were converted to range from 0 to 10 and higher scores indicated greater passivity. 19 Taken together, these measures can be used to generate a profile of the "complex" patient-one with substantial disease burden coupled with a passive approach to disease management. Such a profile has been proposed in other research to represent patients' potential for benefit from treatment and was referred to as the PBS. 8 We also measured problems with adherence to treatment, using a 13-item measure of patient adherence to provider recommendations for medication regimens in the face of specific barriers. 20 Other independent variables included history of CHD, which was abstracted from medical charts and included prior myocardial infarction, angina, coronary revascularization, and heart failure. We also measured regimen complexity as the simple sum of the number of different classes of medications noted in the medical record. Demographic variables including age, sex, ethnicity, time since diagnosis, and years of education were patient-reported.
Statistical Analysis
We used IBM SPSS Statistics v. 20.0 (IBM, Armonk, NY) for all analyses. Univariate and distributional analysis included measures of central tendency, kurtosis, and skew. Bivariate comparisons, were made using Pearson w 2 tests for dichotomous outcomes, and with t tests or 1-way analysis of variance for continuous outcomes. Multivariable ordinary least squares regression models adjusting for age of diagnosis of type 2 diabetes, duration of diabetes, ethnicity, sex, and education were used to evaluate the associations of each independent variable (PBS score, history of CHD, regimen complexity, and problems with adherence) with the CRMP score.
RESULTS
There was no statistically significant relationship between age and patient complexity ( Table 1 ). The most complex patients were less well educated, had had diabetes longer, fewer were male and fewer were white. Patients with a history of CHD were older, more were male, were slightly better educated, had had diabetes longer and more were white compared with those with no history of CHD (Table 1) . Greater complexity was associated with greater regimen intensity as measured by number of classes of medications prescribed (5.1 in the least complex patient vs. 6.7 in the most complex patients, P < 0.001) and the proportion of patients on insulin (18.4% of the least complex vs. 39.0% of the most complex patients, P < 0.001). Compared with those without a history of CHD, those with CHD were on more intensive regimens reflected in the number of classes of medications for risk factor control (7.6 vs. 5.4, P < 0.001). More patients with CHD versus without CHD were on insulin (37.0% vs. 26.7%, P = 0.001) and more were on a statin (84.7% vs. 75.9% for those with and without CHD, respectively; P = 0.004).
Sample-wide, the average CRMP score was 2.3 (SD = 16.7) which reflects cardiometabolic risk factor control that was, on average, 2.3% above recommended targets. CRMP values ranged from À 65.0 to 107.2, and were approximately normally distributed with a median value of À 0.1 and negligible skewness and kurtosis. Among the least complex patients, those who also had a history of CHD had better cardiometabolic risk factor control, compared with those without CHD (CRMP scores À 4.1 vs. 0.2, respectively, P < 0.05; Fig. 1 ). The most complex patients with a history of CHD also had lower CRMP scores (better risk factor control) compared with those without CHD (CRMP scores 0.1 vs. 5.2, respectively; P < 0.05; Fig. 1 ).
Those with heart disease had higher depressive symptom scores (4.1 vs. 3.7, P < 0.05), lower physical function scores (5.7 vs. 6.6, P < 0.001), high TIBI scores but lower scores on the passivity measure (5.1 vs. 5.4, P < 0.05), compared with those without CHD ( Table 2 ). There were no significant differences between the 2 groups in diabetes burden ( Table 2) .
A greater proportion of the most complex patientsreported problems with medication adherence compared with the least complex patients (83.5% vs. 43.3%, respectively, P < 0.001; see Fig. 2 ). However, fewer patients with a history of CHD-reported problems with adherence compared with those without (59.3% vs. 69.3%, respectively, P < 0.01; Fig. 2 ). These associations persisted in logistic regression models adjusted for sex, education, ethnicity, age at diagnosis of diabetes, regimen intensity, and diabetes duration (data not shown). A 1-point increase in PBS score was associated with a greater than 2-fold increase in the odds of reporting problems with adherence (odds ratio 2.2; 95% confidence interval, 1.9, 2.6; P < 0.001). Patients with a history of CHD were significantly less likely to report z P-value computed from 1-way analysis of variance for continuous variables and w 2 test for categorical variables. y Patients with a history of CHD noted in the medical record. 8 Patients with no history of CHD noted in the medical record. z Data on medication regimen intensity were abstracted from medical records. nonadherence (odds ratio 0.7; 95% confidence interval, 0.5, 1.0; P = 0.038).
The most complex patients, as measured by the PBS, had worse control of risk factors (higher CRMP score) adjusted for sex, education, ethnicity, age at diagnosis of diabetes, and diabetes duration (Table 3 ; model 1; P = 0.003). Patients with history of CHD had better risk factor control (lower CRMP score) compared with those without a history of CHD, independent of regimen intensity (P = 0.01). Regimen intensity was not related to risk factor control. When adherence was entered into the model (Table 3 ; model 2), problems with adherence were associated with worse risk factor control (higher CRMP, P = 0.002). History of CHD (P = 0.017), but not patient complexity (P = 0.061), remained significantly associated with risk factor control in model 2.
DISCUSSION
It is both intuitive and consistent with existing literature that for patients with chronic disease, managing a complicated treatment regimen is challenging and often leads to suboptimal adherence. 3, 21, 22 Findings from this study build on this literature to suggest that, independent of the number of medications prescribed, other aspects of patient complexity are associated with poor adherence and poor risk factor control. Contrary to the predictions made in the proposed conceptual model, only Total Illness Burden Index (TIBI), a measure of the presence and severity of conditions comorbid to diabetes and/or heart disease; 7 disease-specific scale scores computed from 38 individual questionnaire items; higher TIBI scores indicate greater comorbidity. [12] [13] [14] zz Provider-Dependent Health Care Orientation Scale, measuring patient passivity; higher scores indicate greater passivity. 19 yy PBS, a composite measure of patient complexity scored as a weighted mean of 5 measures (depressive symptoms, diabetes burden, physical function, TIBI, and passivity), with weights determined by factor loadings on a single factor in principal components analysis.
FIGURE 2.
Comparison of proportion of patients reporting problems with adherence, by level of patient complexity* and by history of coronary heart disease (CHD) (n = 1314). *Measured using the 51-item Potential for Benefit Scale; categories reflect lowest quartile (low), middle 50% (moderate), and highest quartile (high). CI indicates confidence interval.
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Patient Complexity and Risk Factor Control patient complexity but not regimen intensity was independently associated with adherence and risk factor control. The consequences of poor adherence are serious. Up to 50% of treatment failures in chronic disease, resulting in disease progression, functional impairments, hospitalizations, and ultimately mortality, may be related to poor adherence. 23, 24 Among patients with chronic diseases that are largely asymptomatic, such as diabetes, hyperlipidemia, and hypertension, studies show that adherence may be a disturbingly prevalent problem. Roughly one half of patients with such diseases discontinue treatments within 1-2 years of intiation. 25, 26 Being able to identify patients prospectively who are less likely to adhere to medications could help to guide effective strategies tailored to patients' specific needs and circumstances. Such tailored strategies would have greater potential for successful and sustained implementation. It could further allow the physician and patient to consider reducing management burden by modifying or reducing the medication regimen according to the patient's risk for cardiovascular events or future mortality, as guided by risk estimators such as the United Kingdom Prospective Diabetes Study 27 or the Framingham Risk score. 28 However, direct measurement of patient adherence is fraught with welldocumented methodologic challenges. [29] [30] [31] An approach that more accurately identifies complex, already burdened patients (eg, the PBS) that, in turn, is associated both with adherence and with intermediate outcomes, could be useful in identifying those patients with greater and lesser potential for benefit from a new or added treatment.
We also observed that patients with a history of CHD reported better adherence to treatment and better risk factor control, independent of complexity and management burden. Previous studies have suggested that the occurrence of a sentinel cardiovascular event may motivate patients to improve control of their cholesterol and blood pressure by enhancing medication adherence. [32] [33] [34] Consistent with this finding, patients with CHD in this study reported a less passive approach to health care, suggesting that they managed their diabetes more aggressively in the face of added complexity.
Our study has a number of limitations. First, the crosssectional design does not allow for causal assertions regarding the relationships between complexity, adherence, and risk factor control. Second, although the majority of our study population consisted of poor, underserved minority patients at greatest risk for complications from diabetes, we did not include other at-risk racial/ethnic groups (eg, African Americans). Our findings may not therefore be generalizable to a more diverse ethnic or geographic population. Finally, although we had some measures of socioeconomic status, such as education, we did not have information on other indicators of compromised access to care, such as prescription drug benefits that may have affected medication adherence. Therefore, we could not measure the degree of economic stress associated with adherence.
In summary, the presence of a complex health and illness profile was associated with worse control of cardiometabolic risk factors independent of regimen intensity and history of CHD. Those with a history of CHD were more adherent to treatment and had better risk factor control. The occurrence of CHD may increase patient motivation to adhere to their regimens, or present an opportunity for physicians to emphasize effective risk factor management. However, absent such a dramatic event, diabetes patients with a complex illness profile may be at highest risk and in greatest need for effective preventive measures for cardiac disease. *Cardiometabolic risk management profile (CRMP) is a composite measure of cardiovascular event risk computed as the mean proportional distance [(measured value/target value) À1] above or below clinical targets for hemoglobin A1c level (< 7%), systolic blood pressure (< 130 mm Hg), and low-density lipoprotein cholesterol (< 100 mg/dL). A score of 0 was equivalent to all 3 risk factors being at target values. Lower CRMP scores reflected better control of risk factors. Laboratory values, regimen intensity, and history of CHD were abstracted from medical records.
w Results from regression models adjusted for sex, education, ethnicity, age at diagnosis of diabetes, and diabetes duration. Model 2 includes all the independent variables and covariates included in model 1 plus problems with adherence to medication regimen. z Measured using the 51-item Potential for Benefit Scale. y Myocardial infarction or CHD noted in the medical chart. 8 The number of classes of medications for which the patient had a prescription. z Problems with adherence to medication regimen was based on responses to a 13-item scale assessing patient-initiated deviations from the prescribed treatment plan. CI indicates confidence interval.
